Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs

Blood (2023) 142 (17): 1448–1462.

https://doi.org/10.1182/blood.2023021120

Published: 2023

Includes: Supplemental data

Journal Articles

Comparative Analysis of Genome-Scale Gene Regulatory Networks in Human Hematopoietic Stem and Myeloid Progenitor Fractions

Blood (2022) 140 (Supplement 1): 2846–2848.

https://doi.org/10.1182/blood-2022-165620

Published: 2022

Journal Articles

Haematopoietic Progenitor Cell Mobilisation Following Blinatumomab Therapy

Lucy E Cain, Katherine Stephen, Vicki Antonenas, Kay Montgomery, Belinda Meares, Melissa A Gabriel

Blood (2022) 140 (Supplement 1): 12809–12810.

https://doi.org/10.1182/blood-2022-165039

Published: 2022

Journal Articles

Early Administration of Partially HLA Matched Third Party Virus-Specific T-Cells in Conjunction with Antiviral Treatment for Initial Viral Infection after Allogeneic Stem Cell Transplant Is Safe and Leads to High Rates of Viral Control

Wei Jiang, Gaurav Sutrave, Selmir Avdic, Leighton Edward Clancy, Shafqat Inam, Elissa Atkins, Caroline M Bateman, Adrian Gabriel Selim, Vicki Antonenas, Janine Street, Renee Simms, Peter J. Shaw, David Ritchie, Emily Blyth, David J Gottlieb

Blood (2021) 138 (Supplement 1): 255.

https://doi.org/10.1182/blood-2021-152396

Published: 2021

Journal Articles

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac -modified CD19 CAR T cells

Blood (2021) 138 (16): 1504–1509.

https://doi.org/10.1182/blood.2021010813

Published: 2021

Includes: Supplemental data

Journal Articles

Administration of Third-Party Virus-Specific T-Cells (VST) at the Time of Initial Therapy for Infection after Haemopoietic Stem Cell Transplant Is Safe and Associated with Favourable Clinical Outcomes (the R3ACT-Quickly trial)

David Gottlieb, MBBS, MD FRACP, FRCPA, Wei Jiang, MBBS, BSc, BA, Selmir Avdic, PhD, Leighton Clancy, BSc PhD, Gaurav Sutrave, MBBS, Caroline M Bateman, PhDMBBS,FRACP,FRCPath,MRCP, Elissa Atkins, RN, Adrian Gabriel Selim, MBBS, Vicki Antonenas, BSc, David Collins, RN BSc (HONS) MN MapptMgt, Janine Street, BSc MSc (Hons), Renee Simms, BSc, Peter J. Shaw, MA,FRACP, David Ritchie, MD PhD, Emily Blyth, B. MDHons), FRACP, FRCPA, PhD

Blood (2019) 134 (Supplement_1): 251.

https://doi.org/10.1182/blood-2019-125166

Published: 2019

Journal Articles

Results of Using Automated Clinimacs Prodigy for CD34 Selection from Mobilized Peripheral Blood Stem Cell Products

Caroline M Bateman, MDPhDFRCPath, Vicki Antonenas, BSc, Kenneth Yehson, Daochen Tong, Gurdip Hansra, Leighton Edward Clancy, PhD, Peter J. Shaw, MA,FRACP, Kenneth P. Micklethwaite, MBBS, PhD FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 3201.

https://doi.org/10.1182/blood.V130.Suppl_1.3201.3201

Published: 2017

Journal Articles

Infusion of Unrelated-Donor Partially HLA-Matched Cells Results in Detectable Microchimerism in Patients with Acute Myeloid Leukemia: Early Post-Infusion Reactions Are Common but Self-Limiting

David Kliman, MBBS FRACP FRCPA, Emily Blyth, MBBS PhD FRACP FRCPA, Kenneth Yehson, BSc, Vicki Antonenas, BSc MSc, Leighton Clancy, PhD, John Kwan, MBBS FRACP FRCPA, Michael Haeusler, BSc, David Ritchie, MD PhD, David Gottlieb, MBBS MD FRACP FRCPA

Blood (2016) 128 (22): 3405.

https://doi.org/10.1182/blood.V128.22.3405.3405

Published: 2016

Journal Articles

Best Approach for Harvesting Bone Marrow to Maximize TNC and CD34+ Cell Counts

Nalini K Pati, MBBS, MD, DNB, Frances Garvin, BSc, Vicki Antonenas, BSc, Ian Kerridge, FRACP, FRCPA, PhD, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA, David J Gottlieb, MD, FRACP, FRCPA

Blood (2008) 112 (11): 3468.

https://doi.org/10.1182/blood.V112.11.3468.3468

Published: 2008

Journal Articles

Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation

Kenneth P. Micklethwaite, Leighton Clancy, Upinder Sandher, Anna M. Hansen, Emily Blyth, Vicki Antonenas, Mary M. Sartor, Kenneth F. Bradstock, David J. Gottlieb

Blood (2008) 112 (10): 3974–3981.

https://doi.org/10.1182/blood-2008-06-161695

Published: 2008

Journal Articles

Absolute Number of Transplanted CD34 + Cells Expressing c-mpl (CD110) Correlates with Speed of Platelet Engraftment Following Autologous Stem Cell Transplantation.

Mary Sartor, MSc, Frances Garvin, BSc, Vicki Antonenas, MSc, Melina Webb, BSc, Kenneth F. Bradstock, MB, PhD, David J. Gottlieb, MD

Blood (2005) 106 (11): 1078.

https://doi.org/10.1182/blood.V106.11.1078.1078

Published: 2005

Journal Articles

Optimum Temperature for Maintaining the Viability of CD34+ Cells during Storage and Transport of Fresh Hemopoietic Progenitor Cells.

Vicki Antonenas, MSc, Frances Garvin, BSc, Melina Webb, BSc, Mary Sartor, MSc, Kenneth F. Bradstock, MB, PhD, David J. Gottlieb, MD

Blood (2005) 106 (11): 5269.

https://doi.org/10.1182/blood.V106.11.5269.5269

Published: 2005

Journal Articles

Ex-Vivo Expansion and Prophylactic Infusion of CMV pp65 Specific CTL Following Haemopoietic Stem Cell Transplantation (HSCT).

David J. Gottlieb, MD, FRACP, Anna M. Hansen, PhD, Ken P. Micklethwaite, MB, Aaron E. Foster, PhD, Cameron J. Turtle, MB PhD FRACP, Vicki Antonenas, MSc, Mary M. Sartor, MSc, Ken F. Bradstock, MB PhD FRACP

Blood (2005) 106 (11): 3244.

https://doi.org/10.1182/blood.V106.11.3244.3244

Published: 2005

Journal Articles

Recovery of Viable CD34+ Cells from Cryopreserved Haemopoietic Stem Cell Products.

Mary M. Sartor, BSc, MSc, Frances Garvin, BSc, Vicki Antonenas, BSc, MSc, Melina Webb, BSc, Kenneth F. Bradstock

Blood (2004) 104 (11): 5018.

https://doi.org/10.1182/blood.V104.11.5018.5018

Published: 2004

NARROW

Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs

Comparative Analysis of Genome-Scale Gene Regulatory Networks in Human Hematopoietic Stem and Myeloid Progenitor Fractions

Haematopoietic Progenitor Cell Mobilisation Following Blinatumomab Therapy

Early Administration of Partially HLA Matched Third Party Virus-Specific T-Cells in Conjunction with Antiviral Treatment for Initial Viral Infection after Allogeneic Stem Cell Transplant Is Safe and Leads to High Rates of Viral Control

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac -modified CD19 CAR T cells

Administration of Third-Party Virus-Specific T-Cells (VST) at the Time of Initial Therapy for Infection after Haemopoietic Stem Cell Transplant Is Safe and Associated with Favourable Clinical Outcomes (the R3ACT-Quickly trial)

Results of Using Automated Clinimacs Prodigy for CD34 Selection from Mobilized Peripheral Blood Stem Cell Products

Infusion of Unrelated-Donor Partially HLA-Matched Cells Results in Detectable Microchimerism in Patients with Acute Myeloid Leukemia: Early Post-Infusion Reactions Are Common but Self-Limiting

Best Approach for Harvesting Bone Marrow to Maximize TNC and CD34+ Cell Counts

Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation

Absolute Number of Transplanted CD34 + Cells Expressing c-mpl (CD110) Correlates with Speed of Platelet Engraftment Following Autologous Stem Cell Transplantation.

Optimum Temperature for Maintaining the Viability of CD34+ Cells during Storage and Transport of Fresh Hemopoietic Progenitor Cells.

Ex-Vivo Expansion and Prophylactic Infusion of CMV pp65 Specific CTL Following Haemopoietic Stem Cell Transplantation (HSCT).

Recovery of Viable CD34+ Cells from Cryopreserved Haemopoietic Stem Cell Products.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only